Aarti Pharmalabs Ltd

Aarti Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Aarti Pharmalabs Ltd

₹ 841 0.78%
31 Oct 11:30 a.m.
aartipharmalabs.com BSE: 543748 NSE: AARTIPHARM
About

Incorporated in 2019, Aarti Pharmalabs Ltd is a manufacturer of Pharmaceuticals and Nutraceuticals[1]

Key Points

Business Overview:[1]
Aarti Pharmalabs Limited (APL), formerly known as Aarti Organics, was established in 1984 as a WOS of Aarti Industries Limited. Got demerged in Oct,22 into a separately listed entity. Co. is an internationally recognized manufacturer of generic API & Intermediates, Xanthine derivatives, and offers CDMO/CMO services. The company has 6 manufacturing plants and 3 R&D centres.

Website BSE NSE
  • Market Cap ₹ 7,625 Cr.
  • Current Price ₹ 841
  • High / Low ₹ 972 / 550
  • Stock P/E 28.6
  • Book Value ₹ 220
  • Dividend Yield 0.60 %
  • ROCE 17.4 %
  • ROE 14.5 %
  • Face Value ₹ 5.00
Edit ratios

Pros

Cons

  • Promoter holding has decreased over last quarter: -0.84%
  • Company has a low return on equity of 13.6% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE Healthcare BSE SmallCap BSE Allcap Nifty Microcap 250 Nifty Total Market

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
457 531 472 485 458 440 449 506 555 458 538 564 386
371 441 385 405 373 352 353 388 459 364 409 418 293
Operating Profit 86 90 86 80 85 88 96 118 96 94 129 146 93
OPM % 19% 17% 18% 16% 19% 20% 21% 23% 17% 20% 24% 26% 24%
0 1 0 1 0 1 1 2 2 4 5 -2 2
Interest 4 6 5 6 4 4 4 5 5 6 10 7 7
Depreciation 14 17 16 16 17 18 19 19 20 21 23 23 23
Profit before tax 68 69 65 59 64 67 74 96 74 72 101 115 65
Tax % 24% 26% 27% 27% 26% 23% 29% 32% 25% 24% 26% 23% 24%
52 51 48 43 47 52 53 65 55 55 74 88 50
EPS in Rs 5.26 4.73 5.20 5.72 5.82 7.20 6.12 6.03 8.16 9.75 5.46
Raw PDF
Upcoming result date: 9 November 2025

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
-0 1,200 1,945 1,853 2,115 1,946
-0 993 1,603 1,467 1,651 1,484
Operating Profit -0 207 342 386 464 461
OPM % 17% 18% 21% 22% 24%
-0 3 2 5 10 10
Interest -0 12 21 17 27 29
Depreciation -0 42 63 73 87 90
Profit before tax -0 155 261 300 361 352
Tax % 21% 26% 28% 24%
-0 122 193 217 272 266
EPS in Rs 21.35 23.93 30.05 29.40
Dividend Payout % -0% 9% 13% 17%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 21%
TTM: 0%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 31%
TTM: 18%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 31%
Return on Equity
10 Years: %
5 Years: %
3 Years: 14%
Last Year: 15%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 0.25 0.25 45 45 45
Reserves -0 1,386 1,513 1,712 1,945
0 341 215 285 413
-0 312 470 540 503
Total Liabilities 0 2,040 2,244 2,582 2,906
-0 782 926 1,033 1,137
CWIP -0 187 102 137 374
Investments -0 32 87 107 77
0 1,038 1,130 1,305 1,319
Total Assets 0 2,040 2,244 2,582 2,906

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-0 -44 250 216 332
-0 -139 -158 -215 -414
-0 260 -163 10 65
Net Cash Flow -0 78 -71 12 -17

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 115 84 102 99
Inventory Days 272 188 230 190
Days Payable 123 106 135 90
Cash Conversion Cycle 264 166 197 200
Working Capital Days 111 94 110 105
ROCE % 19% 16% 17% 17%

Shareholding Pattern

Numbers in percentages

10 Recently
Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
45.98% 45.98% 46.30% 46.46% 46.46% 46.46% 46.10% 44.65% 44.29% 43.72% 42.88%
7.69% 7.43% 8.45% 8.17% 8.33% 7.07% 7.38% 8.64% 7.36% 7.34% 8.02%
13.68% 10.65% 10.51% 9.91% 9.97% 11.47% 11.35% 10.36% 7.53% 7.80% 6.95%
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
32.64% 35.92% 34.73% 35.45% 35.24% 35.00% 35.17% 36.33% 40.81% 41.12% 42.12%
No. of Shareholders 2,76,6642,58,2392,26,2862,15,7962,04,1221,89,0121,85,4361,85,1111,96,3141,87,0391,90,655

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls